SCIENTIFIC-PRACTICAL JOURNAL

| укр | рус |

 

 


No5(5) 2022

Back to the issue


DOI 10.37219/2528-8253-2022-5-81

Molochek Y, Fediuk O
Evaluation of the clinical efficiency of topical antibacterial therapy of chronic nasopharyngitis after adenotomy 
Molochek Yuri
National specialized children's hospital Ministry of Health of Ukraine OHMATDYT
ENT (Ear, Nose, Throat): Pediatric Otolaryngology
Division Chief
E-mail: y.molochek@gmail.com

Fediuk Oleksii
National specialized children's hospital Ministry of Health of Ukraine OHMATDYT
ENT (Ear, Nose, Throat): Pediatric Otolaryngology
E-mail: alexey.fediuk@gmail.com

Abstract

The presented article provides research, analysis and discussion regarding the rationality and clinical effectiveness of topical antibacterial therapy for chronic nasopharyngitis after adenotomy, in particular the effectiveness of the drug Izofra. Thanks to the study, the effectiveness of the drug Izofra in the postoperative period was substantiated and analysed. The authors obtained valuable information, knowledge and experience thanks to a randomized sample study with the main and control groups, namely, confirmation of the pronounced anti-inflammatory, antibacterial effect of the drug Izofra and its objective rationality of use. Significant reduction of inflammation, reduction of edema, improvement of secretion rheology and increase of local immunity after use of the drug Izofra have been studied and analysed. The topical antibacterial, anti-inflammatory, anti-edematous effect and eradication of planktonic forms of microorganisms (biofilms) of the drug Izofra clinically demonstrated a decrease in the level of postoperative complications, chronicity of the process, relapses and improvement of the postoperative course of treatment of children.

Keywords

chronic nasopharyngitis, adenotomy, local therapy, Izofra, topical antibacterial therapy.


Reference

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600.
  2. Mardikasari SA, Sipos B, Csуka I, Katona G. Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts. Journal of Drug Delivery Science and Technology. 2022;77. https://doi.org/10.1016/j.jddst.2022.103887.
  3. Soldatskiĭ IL, Denisova OA, Ivanenko AM. [The comparative effectiveness of framycetin included in combined therapy of adenoiditis in the children]. Vestn Otorinolaringol. 2014;(5):69-71.
  4. Instructions for the medical use of ISOFRA. Available from: https://mozdocs.kiev.ua/likiview.php?id=2929.
 

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»